Advisory Research’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-1,092
| Closed | -$380K | – | 478 |
|
|
2023
Q3 | $380K | Buy |
1,092
+8
| +0.7% | +$2.78K | 0.05% | 323 |
|
|
2023
Q2 | $381K | Buy |
+1,084
| New | +$381K | 0.05% | 339 |
|
|
2018
Q4 | – | Sell |
-1,144
| Closed | -$220K | – | 401 |
|
|
2018
Q3 | $220K | Buy |
+1,144
| New | +$220K | ﹤0.01% | 352 |
|
|
2018
Q2 | – | Sell |
-1,500
| Closed | -$244K | – | 397 |
|
|
2018
Q1 | $244K | Sell |
1,500
-435
| -22% | -$70.8K | ﹤0.01% | 357 |
|
|
2017
Q4 | $290K | Sell |
1,935
-319
| -14% | -$47.8K | ﹤0.01% | 374 |
|
|
2017
Q3 | $343K | Buy |
+2,254
| New | +$343K | 0.01% | 387 |
|
|
2014
Q2 | – | Sell |
-863
| Closed | -$61K | – | 667 |
|
|
2014
Q1 | $61K | Buy |
+863
| New | +$61K | ﹤0.01% | 754 |
|